At nearly every cardiology conference, whether in Europe or in the United States of America, there is new clinical trial data published. At times so much information is published that the busy clinical cardiologist does not have the time to keep abreast of the latest and preferred therapies. Following the success of Current Issues in Cardiovascular Therapy this successive volume examines advances which have taken place since the earlier book was published, as well as various therapeutic options for the cardiovascular patient and the cost implications for the hospital.